Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
R&D Systems™ Recombinant Human Noggin Protein

Click to view available options
Formulation:
Lyophilized from a 0.2μm filtered solution in PBS with BSA as a carrier protein.
Lyophilized from a 0.2μm filtered solution in PBS.
Description
Measured by its ability to inhibit BMP-4-induced alkaline phosphatase production by ATDC5 mouse chondrogenic cells. The ED50 for this effect is 0.0200-0.160 μg/mL in the presence of 50 ng/mL of Recombinant Human BMP-4 (Catalog # 314-BP ).
This product(s) resides on a Fisher Scientific GSA or VA contract. If you are viewing this page as a nonregistered user, the price(s) displayed is List Price. To view your GSA or VA contract pricing, log in using your account number, or become a registered user by contacting one of our Customer Service teams. You can also view your contract price by searching for this item(s) on GSA Advantage. To place an order, contact Fisher Scientific Customer Service.
Specifications
Specifications
Accession Number | Q13253 |
Characterization | Bioactivity |
For Use With (Application) | Bioactivity |
Formulation | Lyophilized from a 0.2μm filtered solution in PBS with BSA as a carrier protein. |
Gene ID (Entrez) | 9241 |
Molecular Weight (g/mol) | 23kDa (monomer) |
Quantity | 1 mg |
Source | Mouse myeloma cell line,NS0-derived human Noggin protein Gln28-Cys232 |
Storage Requirements | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution. |
Endotoxin Concentration | <0.10EU per 1μg of the protein by the LAL method. |
Show More |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction